Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×
Dec 31, 2021 = ×
Sep 30, 2021 = ×
Jun 30, 2021 = ×
Mar 31, 2021 = ×
Dec 31, 2020 = ×
Sep 30, 2020 = ×
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×
Dec 31, 2018 = ×
Sep 30, 2018 = ×
Jun 30, 2018 = ×
Mar 31, 2018 = ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


The financial data reveals several notable trends in the company's performance over the reported periods. Return on Assets (ROA) shows an initial increase reaching a peak around the early quarters of 2020, followed by a significant decline into negative territory by the first quarter of 2021. After this downturn, ROA gradually recovers and stabilizes in a moderate range without returning to earlier peak levels.

Financial Leverage exhibits a downward trend over the entire period, decreasing from above 2.7 to below 1.9 by the most recent quarter. This indicates a consistent reduction in the company’s use of debt relative to equity, suggesting a strategy of deleveraging or stronger equity financing over time.

Return on Equity (ROE) mirrors the pattern of ROA but with more pronounced fluctuations. Initially, ROE increases significantly, peaking in early 2020 before undergoing a sharp drop into negative values by the beginning of 2021. Subsequent periods show a gradual recovery and moderate growth, though the returned values remain well below the peak levels observed prior to the decline.

Return on Assets (ROA)
Peaked in early 2020, then dropped sharply to negative in early 2021 before slowly recovering to stable but modest positive levels.
Financial Leverage
Demonstrates a general declining trend, decreasing steadily from the highest levels at the start to significantly lower levels by the end of the period, indicating reduced reliance on debt.
Return on Equity (ROE)
Displays a strong increase initially with a peak in early 2020, followed by a pronounced fall into negative figures in early 2021, then recovered gradually to moderate positive values but not reaching prior highs.

Overall, the data suggests the company experienced strong profitability leading up to 2020, which sharply reversed during the early 2021 period. The reduction in financial leverage implies a shift toward a more conservative capital structure over time. Post-2021, profitability ratios show partial recovery and stabilization, reflecting a cautious but improving financial performance trajectory.


Three-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×
Dec 31, 2021 = × ×
Sep 30, 2021 = × ×
Jun 30, 2021 = × ×
Mar 31, 2021 = × ×
Dec 31, 2020 = × ×
Sep 30, 2020 = × ×
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×
Dec 31, 2018 = × ×
Sep 30, 2018 = × ×
Jun 30, 2018 = × ×
Mar 31, 2018 = × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


Net Profit Margin
The net profit margin exhibits significant variability throughout the periods. Initially missing data in early 2018, the margin begins around 17% in the first quarter of 2019, peaking sharply at 43.78% by the first quarter of 2020. After this peak, a decline ensues through late 2020 and early 2021, reaching negative territory at -0.83% in the first quarter of 2021. Subsequently, it recovers steadily to around 10% by the end of 2021. From 2022 onwards, margins stabilize at lower levels between approximately 5% and 8%, indicating moderated profitability in recent quarters.
Asset Turnover
The asset turnover ratio shows a gradual decrease from 0.47 in early 2019 to about 0.32 by the end of 2020, suggesting reduced efficiency in utilizing assets to generate revenue. However, starting in early 2021, a slow but consistent improvement is observed, rising back to 0.40 by the first quarter of 2023. This trend indicates a recent recovery in asset utilization effectiveness.
Financial Leverage
Financial leverage follows a downward trend over the entire period. It begins at 2.73 in early 2018 and decreases steadily to 1.84 by the first quarter of 2023. This consistent decline points to a reduction in the company’s reliance on debt relative to equity, reflecting a potentially more conservative capital structure over time.
Return on Equity (ROE)
ROE data appears from early 2019 with a starting point around 19%, aligning with net profit margin trends. ROE peaks at approximately 34% in the first quarter of 2020, followed by a decline into negative territory (-0.54%) in early 2021. Afterwards, it gradually improves through 2021, reaching around 7% by year-end. In 2022, ROE diminishes again to lower single digits, hovering between roughly 3.7% and 6%. The pattern reflects volatility in profitability and efficiency in generating shareholder returns, largely mirroring fluctuations in net profit margins and asset turnover.

Five-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Sep 30, 2022 = × × × ×
Jun 30, 2022 = × × × ×
Mar 31, 2022 = × × × ×
Dec 31, 2021 = × × × ×
Sep 30, 2021 = × × × ×
Jun 30, 2021 = × × × ×
Mar 31, 2021 = × × × ×
Dec 31, 2020 = × × × ×
Sep 30, 2020 = × × × ×
Jun 30, 2020 = × × × ×
Mar 31, 2020 = × × × ×
Dec 31, 2019 = × × × ×
Sep 30, 2019 = × × × ×
Jun 30, 2019 = × × × ×
Mar 31, 2019 = × × × ×
Dec 31, 2018 = × × × ×
Sep 30, 2018 = × × × ×
Jun 30, 2018 = × × × ×
Mar 31, 2018 = × × × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


Tax Burden
The tax burden ratio fluctuates notably over the observed periods. Starting around 1.18 - 1.1 in 2018-2019, it spikes dramatically in the first half of 2020, peaking at 17.01 before data gaps appear. From 2021 onward, the ratio stabilizes, showing a gradual decline from approximately 1.11 in early 2021 to about 0.61-0.63 in early 2023, indicating improved tax efficiency or changing tax obligations over time.
Interest Burden
The interest burden ratio declines steadily from 0.86 in early 2018 to negative levels around late 2020, reflecting significant interest expense or financial distress during this period. Thereafter, the ratio recovers, rising back above 0.7 by early 2023, suggesting an improvement in the company's ability to cover interest expenses.
EBIT Margin
EBIT margin experienced a downward trend starting around 17% in early 2018, dropping sharply to levels near zero and even 0.52% by late 2020. Subsequently, margins begin to recover steadily, reaching about 12.9% by early 2023. This pattern indicates operational challenges during the mid-period followed by gradual profitability improvement.
Asset Turnover
The asset turnover ratio shows a gradual decline from approximately 0.47 in 2018 to around 0.32 by late 2020. Post-2020, the ratio rises slowly to near 0.40 in early 2023, suggesting a modest enhancement in asset utilization after a period of diminished efficiency.
Financial Leverage
Financial leverage decreases consistently throughout the timeframe, from 2.73 in early 2018 down to about 1.84 by early 2023. This trend reflects a reduction in reliance on debt or other liabilities relative to equity, potentially lowering financial risk.
Return on Equity (ROE)
ROE exhibits significant volatility. After peaking near 19% in early 2019, it surges sharply to over 30% in early 2020 before declining steeply and even turning negative at -0.54% by late 2020. Following this low, ROE shows a gradual recovery, stabilizing around 3.7% to 5.1% in early 2023. Overall, this indicates periods of strong returns interspersed with financial stress and subsequent recovery.

Two-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×
Dec 31, 2021 = ×
Sep 30, 2021 = ×
Jun 30, 2021 = ×
Mar 31, 2021 = ×
Dec 31, 2020 = ×
Sep 30, 2020 = ×
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×
Dec 31, 2018 = ×
Sep 30, 2018 = ×
Jun 30, 2018 = ×
Mar 31, 2018 = ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


The financial indicators demonstrate discernible fluctuations across the reported quarterly periods, reflecting variations in operational efficiency, profitability, and asset utilization.

Net Profit Margin
The margin initially shows a positive trend from the first observed data in March 2019, increasing from 17.01% to a peak of 43.78% in March 2020, indicative of significantly improved profitability during this period. Following this peak, a declining trend is observed through the end of 2020, dropping to 36.65% at December 2020. The margin then experiences a marked decline entering 2021 with negative and low positive margins through the first half, reaching -0.83% in March 2021, before recovering steadily to 10.07% by December 2021. The trend softens throughout 2022, with margins ranging between 5.2% and 8.76%, and a slight improvement is noted in early 2023 rising to 6.91% by March 2023. This overall pattern suggests volatility in profitability, potentially caused by exceptional items or market conditions, with recovery attempts in recent quarters.
Asset Turnover
Asset turnover begins at 0.47 in March 2019 and declines steadily to a low of 0.32 by December 2020, indicating reduced efficiency in using assets to generate sales. From December 2020 forward, a gradual recovery is evident with the ratio increasing incrementally to 0.40 by March 2023. This rebound suggests improvements in asset utilization, possibly through better management or increased sales, offsetting previous declines.
Return on Assets (ROA)
The ROA correlates closely with the trends in net profit margin and asset turnover. Starting at 7.96% in March 2019, it rises to a high of 15.38% in March 2020, reflecting strong profitability and asset use. Following this, a decline takes place reaching -0.27% in March 2021, mirroring the dip in net profit margin. Subsequently, ROA shows progressive recovery, climbing to 3.62% by December 2021 and maintaining moderate levels between 2.04% and 3.23% throughout 2022 and early 2023. The patterns indicate that despite challenges in profit margins and asset efficiency at certain times, the company maintains some capacity to generate returns from its asset base.

In summary, the data reveals a period of strong profitability and operational efficiency in early 2020, followed by a downturn in profitability and asset utilization through 2021. Gradual improvements are discernible from late 2021 onwards, albeit without reaching previous peak levels. The fluctuations suggest the company faced significant challenges affecting its financial performance but has taken steps toward recovery, indicated by improving margins, asset turnover, and returns on assets in recent quarters.


Four-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Sep 30, 2022 = × × ×
Jun 30, 2022 = × × ×
Mar 31, 2022 = × × ×
Dec 31, 2021 = × × ×
Sep 30, 2021 = × × ×
Jun 30, 2021 = × × ×
Mar 31, 2021 = × × ×
Dec 31, 2020 = × × ×
Sep 30, 2020 = × × ×
Jun 30, 2020 = × × ×
Mar 31, 2020 = × × ×
Dec 31, 2019 = × × ×
Sep 30, 2019 = × × ×
Jun 30, 2019 = × × ×
Mar 31, 2019 = × × ×
Dec 31, 2018 = × × ×
Sep 30, 2018 = × × ×
Jun 30, 2018 = × × ×
Mar 31, 2018 = × × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


Tax Burden
The tax burden ratio exhibits significant volatility over the observed periods. Initially around 1.18 in early 2019, it spikes sharply to values as high as 17.01 by mid-2020, indicating periods of extraordinary tax impacts or adjustments. Following this peak, the ratio declines steadily and stabilizes below 1.0 from early 2022 onwards, settling around 0.61 to 0.63 in the first quarter of 2023, which may reflect improved tax expense management or structural changes in tax liabilities.
Interest Burden
The interest burden reflects a downward trend from 0.86 in early 2019 to negative values around the end of 2020, reaching an extreme low of -7.4, indicating severe impacts related to interest expenses or potentially significant non-recurring interest-related charges. Subsequently, this ratio recovers sharply to positive territory by early 2021 and fluctuates between 0.63 and 0.85 through early 2023, suggesting a return to more stable interest expense levels and improving operational performance relative to interest costs.
EBIT Margin
The EBIT margin shows a decreasing trend from the high teens (approximately 18.57%) in mid-2019 down to a low of 0.52% by late 2020, reflecting a noticeable decline in operating profitability during this period. However, subsequent quarters demonstrate a recovery, with the margin rising to 14.07% by the end of 2021. In 2022 and early 2023, the margin stabilizes in the range of 10.81% to 13%, indicating a sustained improvement in operational efficiency and profitability after the previous downturn.
Asset Turnover
The asset turnover ratio shows a gradual declining trend from 0.47 in early 2019 to a low of 0.32 in late 2020, which suggests a reduction in asset utilization efficiency during this interval. From early 2021 onwards, this ratio improves modestly and maintains a fairly stable level around 0.38 to 0.40 through early 2023, implying a moderate recovery in the efficiency of asset use to generate sales.
Return on Assets (ROA)
The ROA metric exhibits a complex pattern, initially decreasing from 7.96% in early 2019 to negative territory (-0.27%) by early 2021, signaling a period of low or negative net profitability relative to asset base. Following this, a gradual improvement occurs with ROA rising to around 3.62% by late 2021, then experiencing some fluctuation but generally remaining between 2.0% and 2.7% through early 2023. This pattern indicates a recovery in the company’s overall effectiveness in generating profit from its assets, though the levels remain moderate.

Disaggregation of Net Profit Margin

Boston Scientific Corp., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×
Dec 31, 2021 = × ×
Sep 30, 2021 = × ×
Jun 30, 2021 = × ×
Mar 31, 2021 = × ×
Dec 31, 2020 = × ×
Sep 30, 2020 = × ×
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×
Dec 31, 2018 = × ×
Sep 30, 2018 = × ×
Jun 30, 2018 = × ×
Mar 31, 2018 = × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).


The analysis of the quarterly financial ratios reveals several noteworthy trends over the periods presented. There is a focus on four key ratios: Tax Burden, Interest Burden, EBIT Margin, and Net Profit Margin.

Tax Burden
The Tax Burden ratio shows variability across the quarters, with values generally fluctuating slightly above and below 1 in the early periods. A significant spike occurs at the March 31, 2020 quarter, reaching 6.84 and then further increasing sharply to 17.01 in June 30, 2020, indicating an unusual tax-related impact during this period. Following this peak, the ratio normalizes and trends downward steadily from the end of 2020 through March 31, 2023, reaching a low of 0.63, suggesting improved tax efficiency or reduced tax expense relative to pre-tax income.
Interest Burden
The Interest Burden ratio initially exhibits a decreasing trend from 0.86 at March 31, 2019 to as low as -7.4 at December 31, 2020, which signals negative operating income or interest costs significantly exceeding operating profits during this interval. Post this downturn, the ratio recovers steadily, rising from negative and near-zero values in late 2020 to a more stable and moderate range from early 2021 through the first quarter of 2023, ending at 0.85. This pattern may indicate volatile interest expenses or non-operational impairments initially followed by stabilization.
EBIT Margin
The EBIT Margin percentage begins at approximately 17% in early 2019 but experiences a downward trajectory through 2020, hitting a low of 0.52% by December 31, 2020. This significant contraction suggests operating profitability was greatly challenged during 2020. However, the margin rebounds strongly through 2021 and stabilizes around the 11-13% range from late 2021 to early 2023, demonstrating recovery in operating performance.
Net Profit Margin
The Net Profit Margin follows a somewhat similar pattern but is more erratic, peaking extraordinarily in early 2020 with values above 39%, which may reflect one-time gains or accounting adjustments. Thereafter, it experiences a steep decline, dropping into negative territory (-0.83%) by March 31, 2021. Subsequent quarters reveal a gradual recovery, with margins stabilizing between 5% and 10% from mid-2021 onwards. Despite the fluctuations, the margin does not return to the exceptionally high pre-decline levels, indicating a new normal in profitability.

Overall, the data reflects significant financial turbulence during 2020, characterized by extreme volatility in key ratios suggestive of operational and financial disruptions. Following this period, a trend toward recovery and stabilization is evident, with improved profitability and more normalized tax and interest burdens through 2021 into early 2023. The patterns imply adaptation to challenging conditions and restoration of financial health over time, though some ratios have not fully returned to former peaks.